The JAMA Diagnostic Test Interpretation article titled “Interpreting SARS-CoV-2 Test Results,” published online on September 17, 2021, included an error in the Discussion that presented an incorrect positive predictive value for a SARS-CoV-2 test. The Discussion has been corrected and indicates that the positive predictive value of the test for the patient was 6.5%. (All other information in the Discussion was correct and is unchanged.)
Source: JAMA Online First
This study examines COVID-19 cases and deaths among US federal and state prisoners from April 5, 2020, to April 3, 2021, compared with cases and deaths in the overall US population.
Source: JAMA Online First
In the Editorial titled “Vasopressin and Steroids as Adjunctive Treatment for In-Hospital Cardiac Arrest,” published online in the September 29, 2021, issue of JAMA, there was a factual error regarding the proportion of patients who received targeted temperature management in the VAM-IHCA trial. The sentence that read, “In the VAM-IHCA trial, all patients received targeted temperature management, although several differences existed between study groups during the postresuscitation period” should have read, “In the VAM-IHCA trial, the proportion of patients who received targeted temperature management was comparable in the intervention group (27%) and in the placebo group (26%), although several differences existed between study groups during the postresuscitation period.” This article was corrected online.
Source: JAMA Online First
This Medical News article is a discussion with elder care expert Terry Fulmer, PhD, RN, about how the US nursing home model can evolve to better serve residents and support workers.
Source: JAMA Online First
This study compares the effect of convalescent plasma vs no convalescent plasma on the outcome of organ support–free days in the hospital among critically ill adults with COVID-19 who had been randomized to the immunoglobulin domain in the ongoing REMAP-CAP trial.
Source: JAMA Online First
This JAMA Guide to Statistics and Methods describes why interim analyses are performed during group sequential trials, provides examples of the limitations of interim analyses, and provides guidance on interpreting the results of interim analyses performed during group sequential trials.
Source: JAMA Online First
This Medical News article discusses clinicians’ enduring stigma toward patients with substance use disorders despite decades of education on the genetic and neurobiological foundations of addiction.
Source: JAMA Online First
Cardiopulmonary arrest occurs in approximately 290 000 hospitalized patients annually in the United States, representing nearly 1% of all admissions and with survival estimated at 20%. To date, most research on cardiopulmonary arrest has focused on patients who experience cardiac arrest in the out-of-hospital setting with results extrapolated to those with cardiac arrest in hospitals. However, there are distinct differences in the treatment of patients who experience cardiac arrest in the hospital setting where disease processes, etiologies, and illness severity differ and medical response time is often shorter.
Source: JAMA Online First
This randomized trial compares the effectiveness of the combination of vasopressin and methylprednisolone vs placebo administered during in-hospital cardiac arrest on return of spontaneous circulation.
Source: JAMA Online First
This study uses toxicology screening data from a health care delivery system to investigate whether rates of cannabis use increased among pregnant women during the COVID-19 pandemic.
Source: JAMA Online First